The ASGCT Annual Meeting will be the world’s largest gathering of gene and cell therapy researchers and provides an international forum where the latest scientific developments are presented and critically discussed. Meet the Cerba Research Team and discover how we are transforming research and advancing health with Cell & Gene therapy!
Meet us at booth 849
Developing Cell and Gene Therapies requires an increased need to access expertise, knowledge, data and insights to bring the right patient to the right treatment at the right time. We facilitate state-of-the-art technology, subject matter expertise, specialized logistics, and operations to accelerate cell and gene therapy development.
Download The Resource Pack
Looking for some extra information after speaking with our experts? Or can’t make it to ASGCT 2023 and still want to discover how we can help you advance your clinical trials? You can download the full Resource Pack by clicking on the link below!
Specialty Lab
Our specialty laboratory solutions can fit into your current clinical development plans. Even if you are using another central laboratory provider, our agile approach and customer-centric view allows you to communicate scientist to scientist easily
Genomics
Since 1992, Cerba Research has pioneered the art of human genetic testing. Thanks to this experience, we are able to collaborate with the life science community to provide the most suitable genomic service and enhance the power of your genetic material.
Flow Cytometry
With 25 years of extensive expertise in providing flow cytometry testing for clinical trials ranging from phase I to phase III, Cerba Research has a strong track record of developing and validating custom-made flow cytometry panels.
Cell & Gene Therapy
Developing Cell and Gene Therapies requires an increased need to access expertise, knowledge, data and insights to bring the right patient to the right treatment at the right time.
Reach out to our experts and discover how we can help you transform your research and advance your clinical trials.